13FTEVA PHARMACEUTICAL INDS LTD (TEVAN)
8 tracked managers currently hold TEVAN on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | ADD | $110.6M | 0.1 % | 0.0 % | 3,265,321 | +1,371,476 |
| Bridgewater Associates, LP | Q2 2026 | ADD | $44.9M | 0.2 % | 0.2 % | 1,326,678 | +198,272 |
| Point72 Asset Management, L.P. | Q2 2026 | TRIM | $35.9M | 0.1 % | 0.1 % | 1,059,778 | -70,729 |
| Duquesne Family Office LLC | Q2 2026 | TRIM | $21.2M | 0.5 % | 2.4 % | 624,999 | -1,752,286 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | TRIM | $7.8M | 0.0 % | 0.0 % | 231,287 | -135,504 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $6.1M | 0.0 % | 0.0 % | 180,647 | +40,574 |
| GREENLIGHT CAPITAL INC | Q4 2023 | NEW | $2.8M | 0.1 % | — | 268,470 | NEW |
| CITADEL ADVISORS LLC | Q2 2026 | NEW | $2.5M | 0.0 % | — | 73,304 | NEW |